For example, for eyes with diabetic ME,33 BRVO,34 and AMD,35 the efficacies of anti-VEGF treatments based on a treat-and-extend regimen have been reported in several clinical studies. The gene discussed is VEGFA; the disease is age-related macular degeneration.